Literature DB >> 56223

Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.

R B Herberman, H T Holden, C C Ting, D L Lavrin, H Kirchner.   

Abstract

Cell-mediated immune reactions appear to play an important role in resistance against growth of leukemia cells in mice. Possible mechanisms for in vivo protection in two tumor systems are discussed. These tumor models, which are a Friend leukemia virus-induced transplantable tumor, FBL-3, and primary murine sarcoma virus (MSV) -induced tumors, are strongly antigenic; under some conditions, tumors regress completely. In mice with regressing FBL-3 tumors, cell-mediated cytotoxicity was measured by release of [125I]iododeoxyuridine. The response was biphasic, with an initial peak at 10 days and a 2nd peak after 30 days. A boost in reactivity could be elicited by later challenge with tumor cells. All of the reactivity was dependent on T-cells, being eliminated by treatment with anti-theta plus complement. The specificity of the reactions was not completely defined, but it was consistent with Friend type-specific antigen plus broader, common antigens. In mice with regressing MSV tumors, strong cell-mediated cytotoxicity, measured mainly by release of 51Cr, was seen against RBL-5, a Rauscher virus-induced leukemia. A single peak of response occurred at about 14 days after virus inoculation. Upon later challenge with RBL-5 cells, a vigorous and rapid secondary response was elicited, mainly in the region of tumor challenge. This cytotoxic reactivity and in vivo resistance to leukemia.lso was completely dependent on T-cells. In addition, macrophage-mediated inhibition of leukemia cell growth in vitro was seen in this system at the time of peak tumor development. The 51Cr release cytotoxicity was specific and directed primarily against an antigen, MEV-SA1, associated with mouse endogenous C-type viruses. The macrophage-induced growth inhibition appeared to be nonspecific. In both the FBL-3 and MSV tumor systems, protection against tumor growth could be adoptively transferred by immune lymphoid cells. In addition to induction of cell-mediated immunity by tumor cell or virus inoculation, cell-mediated cytotoxic reactivity was found to occur naturally in most young mice. This natural killer activity was quite distinct from the experimentally elicited reactions, being mediated by N-cells, a subpopulation of lymphoid cells with no clearly identifiable cell surface markers. The natural cytotoxicity was also directed against antigenic specificities different from those recognized by the MSV-immune cells. The central issue in all of these studies has been to determine the relationships between the in vitro-detected cell-mediated reactivity and in vivo resistance to leukemia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56223

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Natural killer activity: early days, advances, and seminal observations.

Authors:  John R Ortaldo; Robert H Wiltrout; Craig W Reynolds
Journal:  Crit Rev Oncog       Date:  2014

2.  Factors influencing antibody-mediated cytotoxicity during the immunotherapy of Rauscher-virus-induced myeloid leukemic cells.

Authors:  D Berends; T H van der Kwast; N J de Both; P G Mulder
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis.

Authors:  Shaoxin Yang; Wei Lu; Chong Zhao; Yuanmei Zhai; Yanyu Wei; Jiali Liu; Yehua Yu; Zhiqiang Li; Jun Shi
Journal:  Haematologica       Date:  2019-12-19       Impact factor: 9.941

4.  Chemokine (C-X-C motif) ligand 1 maintains the immune surveillance function of natural killer cells via the PDK2/mTOR signaling pathway.

Authors:  Xiaokang Zeng; Xinhuai Dong; Yanning Ma; Jie Yao
Journal:  Cell Biol Toxicol       Date:  2022-03-19       Impact factor: 6.691

5.  Secretory TRAIL-Armed Natural Killer Cell-Based Therapy: In Vitro and In Vivo Colorectal Peritoneal Carcinomatosis Xenograft.

Authors:  Xinxin Song; Se-Hoon Hong; William T Kwon; Lisa M Bailey; Per Basse; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Mol Cancer Ther       Date:  2016-04-12       Impact factor: 6.261

Review 6.  Effects of Radiation on the Tumor Microenvironment.

Authors:  Arta M Monjazeb; Kurt A Schalper; Franz Villarroel-Espindola; Anthony Nguyen; Stephen L Shiao; Kristina Young
Journal:  Semin Radiat Oncol       Date:  2020-04       Impact factor: 5.934

Review 7.  Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.

Authors:  Wei Mu; Zhe Wang; Margot Zöller
Journal:  Front Oncol       Date:  2019-12-16       Impact factor: 6.244

Review 8.  Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function.

Authors:  Joey H Li; Timothy E O'Sullivan
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

9.  Natural cytotoxicity of haemopoietic cell populations against murine lymphoid tumours.

Authors:  R C Burton; D Grail; N L Warner
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

Review 10.  Natural killer cells in cancer biology and therapy.

Authors:  Song-Yang Wu; Tong Fu; Yi-Zhou Jiang; Zhi-Ming Shao
Journal:  Mol Cancer       Date:  2020-08-06       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.